Advanced Colorectal Carcinoma (DBCOND0037890)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06343402
Study of BBO-8520 in Adult Subjects with KRASG12C Non-small Cell Lung and Colorectal Cancertreatment1recruiting
NCT04535401
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestinestreatment1active_not_recruiting
NCT04704661
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trialtreatment1recruiting
NCT05969860
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients with Advanced CancerNo drug interventionshealth_services_research2recruiting
NCT05967533
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint InhibitorsNo drug interventionstreatment1recruiting
NCT05883683
Molecular Study and Precision Medicine for Colorectal CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06555588
Engage Psychosocial Intervention for Cancer SymptomsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT04771715
Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal CancerNot AvailableNot Availableunknown_status
NCT05200442
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancertreatment1 / 2recruiting
NCT05406206
Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapytreatment2recruiting
NCT01277406
4SC-201 (Resminostat) in Advanced Colorectal Carcinomatreatment1 / 2completed
NCT05648006
First-line Maintenance of OH2 Injection for Advanced Colorectal Cancertreatment2terminated
NCT01208194
Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal CarcinomaNo drug interventionstreatment2completed
NCT05894694
Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancertreatment4recruiting
NCT04645797
A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver LesionsNo drug interventionstreatment1completed
NCT02983578
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancertreatment2active_not_recruiting
NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumorstreatment2recruiting
NCT04705818
Combining Epigenetic And Immune Therapy to Beat Cancer.treatment2recruiting
NCT04109924
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Studytreatment2active_not_recruiting
NCT06521866
Toripalimab Combined With Targeted Therapy and Chemotherapy With or Without Radiotherapy as First-Line Treatment for Advanced Colorectal Cancertreatment2not_yet_recruiting
NCT04164069
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumabprevention1active_not_recruiting
NCT04582981
Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancertreatment2unknown_status
NCT00499850
Phase I FOLFOX Combinationtreatment1completed
NCT05759923
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid TumoursNo drug interventionstreatment1recruiting